Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia

Recruiting now

Conditions studied: Acute Myeloid Leukemia (AML), MLL Rearrangement

In brief

The goal of this observational study is to learn about the predict value of leukemia stem cell for acute myeloid leukemia patients with MLL-rearrangement. The main question it aims to answer is: • Could be leukemia stem cell used for relapse prediction in acute myeloid leukemia patients with MLL-rearrangement? Leukemia stem cell will be detected at the same time for participants who detected minimal residual disease using bone marrow as part of their regular medical care to answer the question.

Key facts

Study ID

NCT07537738

Run by

Peking University People's Hospital

People needed

210

Starts

2025-06-01

Expected to finish

2026-04-07

Last updated by the study team

2026-04-17

Who can join

Age: 6 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Acute myeloiud leukemia patients with MLL arrangement aging 6-60 years recieving chemoterapy or allo-geneic hematopoietic stem cell transplantation.

You may not qualify if…

• Patients who cannot recieve chemoterapy or allo-geneic hematopoietic stem cell transplantation.
• Patients who cannot comply with the study.

Where it is running

• Peking University People's Hospital — Beijing, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.